MIM
LMAT icon

Macroview Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Macroview Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-137
Closed -$12.7K – 334
2024
Q3 		$12.7K Sell
137
-5
-4% -$433 0.01% 213
2024
Q2 		$11.7K Buy
142
+99
+230% +$7.27K 0.01% 220
2024
Q1 		$2.85K Hold
43
– – ﹤0.01% 485
2023
Q4 		$2.44K Sell
43
-141
-77% -$7.39K ﹤0.01% 499
2023
Q3 		$10K Buy
+184
New +$10.9K 0.01% 265

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macroview Investment Management's LMAT Position: Q4 2024 in Review

Macroview Investment Management sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 137 shares — an estimated $12.7K sold.

Macroview Investment Management first reported a position in LMAT in Q3 2023 and held it in 5 quarters. The position peaked at $12.7K in Q3 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

  • Macroview Investment Management reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 137 LeMaitre Vascular shares in Q4 2024, an estimated $12.7K.
  • Macroview Investment Management first reported a position in LeMaitre Vascular in Q3 2023 and held it in 5 quarters.
  • Macroview Investment Management's LeMaitre Vascular position peaked at $12.7K in Q3 2024.
  • 307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.